Brief: Nymox Receives RTF Letter From FDA

Nymox Pharmaceutical

23/05/2022 13:58

May 23 (Reuters) - Nymox Pharmaceutical Corp  NYMX.O :
    * NYMOX RECEIVES RTF LETTER FROM FDA
    * NYMOX - NYMOX'S POSITION IS THAT CLARIFICATIONS REMAIN TO
BE
RESOLVED AT A FOLLOW-UP MEETING AND THAT SOME SIGNIFICANT
INCONSISTENCIES WERE INVOLVED
    * NYMOX - RECEIVED A RTF LETTER FROM FDA ON FRIDAY MAY 20TH
AT
2:48 PM EST, WITH REGARD TO COMPANY'S NDA FOR FEXAPOTIDE
TRIFLUTATE

Source text for Eikon:  ID:nGNX9S0CwP 
Further company coverage:  NYMX.O 

 ((Reuters.Briefs@thomsonreuters.com;))